Wednesday, July 23, 2014

Top Mid Cap Companies To Invest In Right Now

Morningstar (MORN) has named the five 2013 U.S. Fund Manager of the Year award winners. Winners include portfolio managers with Morgan Stanley (MS), Artisan, PIMCO, FPA and AQR.

In the domestic stock fund category, the award went to Dennis Lynch and the 18-member U.S. growth team for four funds: Morgan Stanley Focus Growth (AMOAX), Morgan Stanley Institutional Growth (MSEQX), Morgan Stanley Institutional Mid Cap Growth (MPEGX) and Morgan Stanley Institutional Small Company Growth (MSSGX). These four funds each posted returns of more than 35% last year.

“The team operates in areas of the market that have seen the strongest runs [in 2013],” said Scott Burns, Morningstar’s director of global fund research, in a press release. “The degree of outperformance as well as patience with long-held and often controversial holdings, including Facebook and Groupon, make the team deserving of the 2013 award for the successful execution of the funds’ strategy.”

Best Undervalued Stocks To Invest In Right Now: Halcon Resources Corp (HK)

Halcon Resources Corporation (Halcon Resources), incorporated on February 5, 2004, is an independent energy company focused on the acquisition, production, exploration and development of onshore liquids-rich oil and natural gas assets in the United States. The Company has oil and natural gas reserves located primarily in Texas, North Dakota, Louisiana, Oklahoma and Montana. On August 1, 2012, the Company acquired GeoResources by merger. On December 6, 2012, the Company completed the acquisition of entities owning approximately 81,000 net acres prospective for the Bakken / Three Forks formations primarily located in Williams, Mountrail, McKenzie and Dunn Counties, North Dakota (the Williston Basin Assets), from Petro-Hunt, L.L.C. and Pillar Energy, LLC (the Petro-Hunt parties). As of December 31, 2012, the Company has working interests in approximately 128,000 net acres prospective for the Bakken / Three Forks formations in North Dakota and Montana.

The Company�� Woodbine / Eagle Ford acreage is prospective for the Woodbine, Eagle Ford and other formations, with targeted depths ranging anywhere from 7,000 feet to 10,400 feet. As of December 31, 2012, The Company has approximately 198,000 net acres leased or under contract primarily in Leon, Madison, Grimes, Brazos, and Polk Counties, Texas. The Company is the operator and has a 100% working interest in more than 12,000 net acres in Wichita and Wilbarger Counties, Texas that it is actively water flooding in shallow Cisco aged Pennsylvania sandstone and limestone reservoirs. As of December 31, 2012, the Company produced 484 million barrels of oil equivalent from approximately 700 active producing wells and approximately 230 active water injection wells.

The Company�� position in the La Copita Field covers 3,720 gross acres and 2,829 net acres in Starr County, Texas. As of December 31, 2012, the Company�� average net daily production was 623 barrels of oil equivalent per day. The Company operates 100% of this production a! nd its working interest ranges from 75% to 100%. The Company has various other oil and natural gas properties with varying working interests located across the United States, including the Austin Chalk Trend and Eagle Ford Shale in Texas, the Fitts-Allen Fields in Central Oklahoma, and various other areas across South Louisiana, Montana, North Dakota, New Mexico, and West Virginia.

Advisors' Opinion:
  • [By Tyler Crowe]

    Who's next?
    Kodiak Oil & Gas isn't the only one that has employed this growth strategy in the Bakken, and several other companies that are either Bakken-centric or have smaller assets in the region will also struggle with these new regulations. The companies that immediately come to mind are Oasis Petroleum and Triangle Petroleum because they are pure plays, but two other companies that could be at risk here are Halcon Resources (NYSE: HK  ) and Magnum Hunter Resources (NYSE: MHR  ) . While Magnum Hunter and Halcon do have assets elsewhere, they have both been using the Bakken as a production base to generate revenue while they explore less established shale formations. Based on the cash flow at these companies, they can ill afford to see production limited in the Bakken.

  • [By Adam Haigh]

    Hong Kong�� Hang Seng Index yesterday rose past 24,000 for the first time since April 2011, before declining 0.1 percent at the close. Equities traded in the city will extend their rally on optimism about China�� biggest package of policy changes since the 1990s and a stronger global economy, according to investors from JPMorgan Asset Management to Pictet Asset Management (HK) Ltd.

Top Mid Cap Companies To Invest In Right Now: Ecopetrol S.A.(EC)

Ecopetrol S.A. operates as an integrated oil company in Colombia, Peru, Brazil, and the U.S. Gulf Coast. The company engages in the exploration, development, and production of crude oil and natural gas. As of December 31, 2010, its proved reserves of crude oil and natural gas consisted of 1,714.0 million barrels of oil equivalent. The company also transports crude oil, motor fuels, fuel oil, and other refined products, as well as mixture of diesel and palm oil. It owns transportation network consisting of 3,003 kilometers of crude oil pipeline directly, as well as an additional 2,178 kilometers of crude oil pipeline with its business partners; and 3,017 kilometers of multi-purpose pipelines for transportation of refined products from refinery to wholesale distribution points. As of the above date, Ecopetrol S.A. owned 58 stations with a nominal storage capacity of 19 million barrels of crude oil and 6 million barrels of refined products. In addition, the company owns and o perates refineries that produce a range of refined products, including gasoline, diesel, kerosene, jet fuel, aviation fuel, liquefied petroleum gas, sulfur, heavy fuel oils, motor fuels, and petrochemicals, including paraffin waxes, lube base oils, low-density polyethylene, aromatics, asphalts, alkylates, cyclohexane and aliphatic solvents, and refinery grade propylene, as well as provides industrial services to third parties. Further, it markets various refined and feed stock products, including regular and high octane gasoline, diesel fuel, jet fuel, natural gas, and petrochemical products. The company was formerly known as Empresa Colombiana de Petroleos and changed its name to Ecopetrol S.A. in June 2003. Ecopetrol S.A. was founded in 1948 and is based in Bogota, Colombia.

Advisors' Opinion:
  • [By Rich Duprey]

    Looking to modernize its Cartagena refinery in Colombia, Ecopetrol's (NYSE: EC  ) board of directors has approved spending more than half a billion additional dollars this year on an upgrade. The full project is estimated to cost nearly $6.5 billion.

  • [By Dividend]

    Ecopetrol (EC) has a market capitalization of $94.96 billion. The company employs 8,087 people, generates revenue of $35.317 billion and has a net income of $7.863 billion. Ecopetrol�� earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $15.070 billion. The EBITDA margin is 42.67 percent (the operating margin is 35.23 percent and the net profit margin 22.26 percent).

  • [By GuruFocus]

    Ecopetrol S.A. (EC) Reached the 52-Week Low of $38.85

    The prices of Ecopetrol S.A. (EC) shares have declined to close to the 52-week low of $38.85, which is 41.5% off the 52-week high of $64.06. Ecopetrol S.A. is owned by 2 Gurus we are tracking. Among them, 1 has added to their positions during the past quarter. 2 reduced their positions.

Top Mid Cap Companies To Invest In Right Now: Genomma Lab Internacional SAB de CV (LABB.MX)

Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company�� product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. Advisors' Opinion:
  • [By Ben Levisohn]

    He then took a deep dive into Genomma Lab�(LABB.MX), a Mexican producer of over-the counter pharmaceuticals, generic drugs, and personal care products. Now, I’m sitting with a Chromebook in a large auditorium, so I hope I’ve captured the essence of his argument.

Top Mid Cap Companies To Invest In Right Now: Cytori Therapeutics Inc(CYTX)

Cytori Therapeutics, Inc. engages in the development, manufacture, and sale of medical products and devices to enable the practice of regenerative medicine. Regenerative medicines focus on repairing or restoring lost or damaged tissue and cell function. Its principal products include the Celution family of products, which processes patients' adipose-derived stem and regenerative cells (ADRCs) at the point of care. The Celution family of products consists of a central device, a related single-use consumable used for each patient procedure, proprietary enzyme reagents, and related instrumentation. Its core product, the Celution System, provides physicians with clinical grade stem and regenerative cells for use in the cosmetic and reconstructive surgery market. The company also provides PureGraft, a consumable product that provides grafts for use in aesthetic body contouring procedures. In addition, it sells the StemSource family of products worldwide, including in the United States, for research, as well as for the cryopreservation and storage of ADRCs. It offers the StemSource System as a standalone product, or as a part of a comprehensive suite of systems, equipment, and protocols collectively referred to as a StemSource Cell Bank. Further, the company develops Celution System, which has completed two clinical trials for applications in cardiovascular disease, wound healing, gastrointestinal disorders, stress urinary incontinence, liver and renal disease, spinal disc degeneration, and pelvic health conditions. It has strategic development and manufacturing joint venture agreement, and other related agreements with Olympus Corporation. The company was formerly known as MacroPore Biosurgery, Inc. Cytori Therapeutics, Inc. was founded in 1996 and is headquartered in San Diego, California.

Advisors' Opinion:
  • [By James E. Brumley]

    If you're reading this, then odds are you already know that Cytori Therapeutics Inc. (NASDAQ:CYTX) is up a whopping 8% today. In some ways that's encouraging, as it proves there's a lot of trade-worthy momentum to be tapped. In other ways, however, it's bad, because CYTX is overbought and ripe for a pullback. No matter how you're seeing Cytori Therapeutics in the short run, though, when you take a step back and look at the longer-term picture, there's a lot to like.

Top Mid Cap Companies To Invest In Right Now: Viad Corp(VVI)

Viad Corp, together with its subsidiaries, operates in exhibition and events, and travel and recreation industries primarily in North America, the United Kingdom, Germany, and the United Arab Emirates. The company?s Marketing & Events Group segment designs, plans, and produces face-to-face events for show organizers, corporate brand marketers, and retail shopping centers. It offers general event management, planning and consultation, concept design, exhibition layout and design, graphics and design, show traffic analysis, carpeting and flooring, decorating products and accessories, custom graphics, overhead rigging, and cleaning services, as well as temporary electrical, lighting, and plumbing services. This segment also provides custom exhibit design and construction; portable and modular exhibits and design; integrated marketing, including pre- and post-event communications and customer relationship management; multimedia services; event surveys; return on investment an alysis; attendee and exhibit booth traffic analysis; staff training; online management tools; logistics and freight-forwarding, storage, and refurbishment of exhibits; booth furnishings, carpeting, and signage; in-house installation and dismantling; and various other show services. In addition, the segment offers various entertaining attractions and brand-based experiences, sponsored events, mobile marketing and other branded entertainment, and face-to-face marketing solutions for clients and venues, including movie studios, leading consumer brand marketers, shopping malls, museums, and casinos. Its Travel & Recreation Group segment provides tourism products, including attractions, transportation services, inbound package tour operations, hotel operations, and corporate and event management; operates five lodges, three motor inns, and one resort hotel; and engages in food and beverages, and retail and concession businesses. Viad Corp was founded in 1914 and is headquartered in Phoenix, Arizona.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Viad Corp (NYSE: VVI  ) , whose recent revenue and earnings are plotted below.

No comments:

Post a Comment